The organoid-forming potential of EAC PDOs was increased when treated with Torin-1, an inhibitor of the mammalian target of rapamycin (mTOR), and reduced with mTOR stimulation with MHY1485, suggesting a role for mTOR in regulating stemness of cancer cells (Du et al., 2022). Here, MTOR is linked to cancer.